007460.KS
Aprogen Medicines Inc.
KSC · Industrials · Industrial - Machinery · KR
KRW 1,897.00
−2.22%Year over year
Reported trailing growth
- Revenue
- +9.1%
- EBITDA
- -73.4%
- EBIT
- -2.0%
- EPS
- +31.1%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +14.6%
- EBITDA
- -55.3%
- EBIT
- -63.0%
- Net income
- -19.6%
- EPS
- -3.9%
- Free cash flow
- +37.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026